INTERMUNE (NASDAQ:ITMN)
10.79
0.09 (0.83%)
| INTERMUNE (NASDAQ:ITMN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $10.88 | 52 Week High | $19.12 | ||
| Open | $10.87 | 52 Week Low | $8.66 | ||
| Day High | $11.01 | P/E | N/A | ||
| Day Low | $10.65 | EPS | $-2.86 | ||
| Volume | 488,852 | ||||
| More ITMN Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| VRUS | 4 | TYC | 2 |
| WFC | 2 | PLA | 2 |
| CSTR | 2 | ALKS | 2 |
| SMTL | 2 | DRYS | 2 |
| SNDK | 2 | TRID | 2 |
| ACHN | 1 | ARTNA | 1 |
Entities who have mentioned ITMN
- Merriman Curhan Ford | View Related Stories »
- UBS | View Related Stories »
- S3 | View Related Stories »
- Deutsche Bank | View Related Stories »
- Dividend | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Steven A. Cohen | View Related Stories »
- Jefferies & Co | View Related Stories »
- Scopia Capital | View Related Stories »
- Robert W Baird | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- JMP Securities | View Related Stories »
- Natixis Bleichroeder | View Related Stories »
- Piper Jaffray | View Related Stories »
- SAC Capital | View Related Stories »
- ThinkEquity | View Related Stories »
- Carl Icahn | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- GLG Partners | View Related Stories »
- Trading Radar | View Related Stories »
- Raymond James | View Related Stories »
- Rodman & Renshaw | View Related Stories »
- Needham & Co | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
View All Major News StreetInsider.com Major News for ITMN
- InterMune (ITMN) Reports Smaller-Than-Expected Loss; Guides In-line
- InterMune Inc. (ITMN) Misses Q2 View
- InterMune (ITMN) Reports Q1 Loss of $1.03; Guides FY09 Sales
View All ReportsStreetInsider.com Reports on ITMN
- Morning Movers 11/17: ZOOM, SMTL, AGO, ABCW, XJT Higher; INOC, QUIK, PSUN, ERI, FTK, TBUS Lower
- InterMune (ITMN) Modifies On-Going Phase 2b Study of ITMN-191
- InterMune (ITMN) Reports Smaller-Than-Expected Loss; Guides In-line
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- InterMune (ITMN) Higher Following INFORM-1 Trial Data
View All Press ReleasesCompany Press Releases on ITMN
- InterMune Announces Modification to On-Going Phase 2b Study of ITMN-191 in Patients with Chronic HCV Infection
- InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
- InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
- InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
- INFORM-1 Results: Robust Antiviral Suppression Achieved with Combination of Nucleoside Analog Polymerase Inhibitor RG7128 and Protease Inhibitor RG7227
StreetInsider Reports on ITMN by Category
View All BlogsBlogs on ITMN
- InterMune, Inc. Q3 2009 Earnings Call Transcript
- Biotech Busy with Bevy of Small Deals
- Options Trader Tuesday Outlook: S&P 1,010 Edition
- Analyst upgrades, downgrades and initiations: ALL, CMG, GRMN, IP, VRSN ...
- 30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
View All FilingsSEC Filings on ITMN
- Form 8-K INTERMUNE INC For: Nov 17
- Form 4 Di Nepi Giacomo For: Nov 06
- Form 10-Q INTERMUNE INC For: Sep 30
- Form 8-K INTERMUNE INC For: Nov 05
- Form 8-K INTERMUNE INC For: Nov 04
Comments on ITMN
No comments are currently available.
